Electrospun Structural Hybrids of Acyclovir-Polyacrylonitrile at Acyclovir for Modifying Drug Release

In traditional pharmaceutics, drug–crystalline nanoparticles and drug–polymer composites are frequently explored for their ability to modify drug release profiles. In this study, a novel sort of hybrid with a coating of acyclovir crystalline nanoparticles on acyclovir-polyacrylonitrile composites wa...

Full description

Bibliographic Details
Main Authors: He Lv, Shiri Guo, Gaoyi Zhang, Wanli He, Yonghui Wu, Deng-Guang Yu
Format: Article
Language:English
Published: MDPI AG 2021-12-01
Series:Polymers
Subjects:
Online Access:https://www.mdpi.com/2073-4360/13/24/4286
_version_ 1797501231700115456
author He Lv
Shiri Guo
Gaoyi Zhang
Wanli He
Yonghui Wu
Deng-Guang Yu
author_facet He Lv
Shiri Guo
Gaoyi Zhang
Wanli He
Yonghui Wu
Deng-Guang Yu
author_sort He Lv
collection DOAJ
description In traditional pharmaceutics, drug–crystalline nanoparticles and drug–polymer composites are frequently explored for their ability to modify drug release profiles. In this study, a novel sort of hybrid with a coating of acyclovir crystalline nanoparticles on acyclovir-polyacrylonitrile composites was fabricated using modified, coaxial electrospinning processes. The developed acyclovir-polyacrylonitrile at the acyclovir nanohybrids was loaded with various amounts of acyclovir, which could be realized simply by adjusting the sheath fluid flow rates. Compared with the electrospun composite nanofibers from a single-fluid blending process, the nanohybrids showed advantages of modifying the acyclovir release profiles in the following aspects: (1) the initial release amount was more accurately and intentionally controlled; (2) the later sustained release was nearer to a zero-order kinetic process; and (3) the release amounts at different stages could be easily allocated by the sheath fluid flow rate. X-ray diffraction results verified that the acyclovir nanoparticles were in a crystalline state, and Fourier-transform infrared spectra verified that the drug acyclovir and the polymer polyacrylonitrile had a good compatibility. The protocols reported here could pave the way for developing new types of functional nanostructures.
first_indexed 2024-03-10T03:15:25Z
format Article
id doaj.art-4987c5599e1647e18b23b148a8832bee
institution Directory Open Access Journal
issn 2073-4360
language English
last_indexed 2024-03-10T03:15:25Z
publishDate 2021-12-01
publisher MDPI AG
record_format Article
series Polymers
spelling doaj.art-4987c5599e1647e18b23b148a8832bee2023-11-23T10:14:08ZengMDPI AGPolymers2073-43602021-12-011324428610.3390/polym13244286Electrospun Structural Hybrids of Acyclovir-Polyacrylonitrile at Acyclovir for Modifying Drug ReleaseHe Lv0Shiri Guo1Gaoyi Zhang2Wanli He3Yonghui Wu4Deng-Guang Yu5School of Materials and Chemistry, University of Shanghai for Science and Technology, Shanghai 200093, ChinaSchool of Materials and Chemistry, University of Shanghai for Science and Technology, Shanghai 200093, ChinaSchool of Optical-Electrical and Computer Engineering, University of Shanghai for Science and Technology, Shanghai 200093, ChinaSchool of Materials and Chemistry, University of Shanghai for Science and Technology, Shanghai 200093, ChinaThe Department of Mechanical Engineering, Guangxi Technological College of Machinery and Electricity, Nanning 530007, ChinaSchool of Materials and Chemistry, University of Shanghai for Science and Technology, Shanghai 200093, ChinaIn traditional pharmaceutics, drug–crystalline nanoparticles and drug–polymer composites are frequently explored for their ability to modify drug release profiles. In this study, a novel sort of hybrid with a coating of acyclovir crystalline nanoparticles on acyclovir-polyacrylonitrile composites was fabricated using modified, coaxial electrospinning processes. The developed acyclovir-polyacrylonitrile at the acyclovir nanohybrids was loaded with various amounts of acyclovir, which could be realized simply by adjusting the sheath fluid flow rates. Compared with the electrospun composite nanofibers from a single-fluid blending process, the nanohybrids showed advantages of modifying the acyclovir release profiles in the following aspects: (1) the initial release amount was more accurately and intentionally controlled; (2) the later sustained release was nearer to a zero-order kinetic process; and (3) the release amounts at different stages could be easily allocated by the sheath fluid flow rate. X-ray diffraction results verified that the acyclovir nanoparticles were in a crystalline state, and Fourier-transform infrared spectra verified that the drug acyclovir and the polymer polyacrylonitrile had a good compatibility. The protocols reported here could pave the way for developing new types of functional nanostructures.https://www.mdpi.com/2073-4360/13/24/4286coaxial electrospinningstructural hybridspolymeric nanocompositesmodified releasemedicated nanomaterials
spellingShingle He Lv
Shiri Guo
Gaoyi Zhang
Wanli He
Yonghui Wu
Deng-Guang Yu
Electrospun Structural Hybrids of Acyclovir-Polyacrylonitrile at Acyclovir for Modifying Drug Release
Polymers
coaxial electrospinning
structural hybrids
polymeric nanocomposites
modified release
medicated nanomaterials
title Electrospun Structural Hybrids of Acyclovir-Polyacrylonitrile at Acyclovir for Modifying Drug Release
title_full Electrospun Structural Hybrids of Acyclovir-Polyacrylonitrile at Acyclovir for Modifying Drug Release
title_fullStr Electrospun Structural Hybrids of Acyclovir-Polyacrylonitrile at Acyclovir for Modifying Drug Release
title_full_unstemmed Electrospun Structural Hybrids of Acyclovir-Polyacrylonitrile at Acyclovir for Modifying Drug Release
title_short Electrospun Structural Hybrids of Acyclovir-Polyacrylonitrile at Acyclovir for Modifying Drug Release
title_sort electrospun structural hybrids of acyclovir polyacrylonitrile at acyclovir for modifying drug release
topic coaxial electrospinning
structural hybrids
polymeric nanocomposites
modified release
medicated nanomaterials
url https://www.mdpi.com/2073-4360/13/24/4286
work_keys_str_mv AT helv electrospunstructuralhybridsofacyclovirpolyacrylonitrileatacyclovirformodifyingdrugrelease
AT shiriguo electrospunstructuralhybridsofacyclovirpolyacrylonitrileatacyclovirformodifyingdrugrelease
AT gaoyizhang electrospunstructuralhybridsofacyclovirpolyacrylonitrileatacyclovirformodifyingdrugrelease
AT wanlihe electrospunstructuralhybridsofacyclovirpolyacrylonitrileatacyclovirformodifyingdrugrelease
AT yonghuiwu electrospunstructuralhybridsofacyclovirpolyacrylonitrileatacyclovirformodifyingdrugrelease
AT dengguangyu electrospunstructuralhybridsofacyclovirpolyacrylonitrileatacyclovirformodifyingdrugrelease